Xifaxan (rifaximin) clears from your body quickly, largely because it barely enters your bloodstream in the first place. Less than 0.4% of each dose is absorbed into systemic circulation. The vast majority, about 97%, passes through your digestive tract and leaves your body unchanged in your stool. In clinical trials reviewed by the FDA, researchers used a washout period of just over 5 days after the last dose to consider the drug fully cleared.
Why Xifaxan Leaves So Quickly
Unlike most antibiotics that travel through your blood to reach infections throughout the body, Xifaxan is designed to stay in your gut. It works locally in the intestines, which is why it’s prescribed for conditions like traveler’s diarrhea, irritable bowel syndrome with diarrhea (IBS-D), and hepatic encephalopathy. Because the drug isn’t meaningfully absorbed, there’s very little circulating in your blood that needs to be processed and eliminated.
In healthy volunteers given a radiolabeled dose (a version of the drug that can be tracked precisely), 96.62% of the drug was recovered in feces as the unchanged compound. Only 0.32% showed up in urine, mostly as breakdown products rather than the drug itself. The total recovery over 168 hours (7 days) was about 97%, confirming that the drug doesn’t linger or accumulate in tissues.
How Long It Stays in Your Blood
The tiny fraction of Xifaxan that does reach your bloodstream peaks fast and disappears fast. After a single 550 mg dose taken on an empty stomach, plasma levels peak at a median of about 45 minutes. But even at peak, the concentration is extremely low, averaging around 4 ng/mL. To put that in perspective, that’s roughly four billionths of a gram per milliliter of blood.
Repeated dosing doesn’t change this picture much. In a study of volunteers taking 200 mg three times daily, blood levels on day 1 and day 3 were essentially identical, with no signs of the drug building up over time. The peak concentration on day 3 (after nine doses) was actually slightly lower than on day 1. This means that each dose is cleared before the next one adds anything meaningful to what’s already circulating.
The 5-Day Clearance Window
When the FDA reviewed clinical trial data for Xifaxan’s approval, the agency used a cutoff of greater than 5 days after the last dose to define the washout period. Any side effects appearing after that window were considered unrelated to the drug. This gives a practical answer: within roughly 5 to 7 days of your last pill, the drug and its trace metabolites are essentially gone from your system.
For the gut specifically, clearance depends on your individual transit time. Most people move food through the digestive tract in 24 to 72 hours, so the bulk of the unabsorbed drug leaves with normal bowel movements within a few days of stopping treatment.
Factors That Could Affect Clearance
Liver function is the most significant variable. Xifaxan is commonly prescribed for people with liver disease, and impaired liver function can increase the amount of drug that reaches the bloodstream. In patients with advanced liver cirrhosis, systemic exposure can be substantially higher than in healthy individuals. If you have liver disease, the small absorbed fraction may take longer to be processed, though the drug still primarily exits through the gut.
Food can also influence absorption. Taking Xifaxan with a high-fat meal increases the amount that enters the bloodstream compared to taking it on an empty stomach. This doesn’t change the overall clearance timeline dramatically, but it means slightly more of the drug reaches systemic circulation when taken with food.
Gut motility matters too. If you have slower-than-normal bowel movements (from medications, medical conditions, or other causes), the unabsorbed drug will sit in your intestines longer before being excreted. Conversely, diarrhea can speed the passage of the drug through your system.
Drug Testing and Interactions
Xifaxan is not a controlled substance and is not part of standard drug screening panels. If you’re concerned about it showing up on a test, it won’t appear on typical employment or medical drug screens.
Because so little of the drug reaches the bloodstream, it has a very low potential for interacting with other medications that are processed by the liver. This is one of the reasons it’s considered relatively safe for long-term use in conditions like hepatic encephalopathy, where patients often take it continuously for months. The drug does not accumulate with repeated dosing, so the clearance timeline remains consistent whether you’ve been taking it for 2 weeks or 6 months.